Health-related quality of life following FDG-PET/CT for cytological indeterminate thyroid nodules

Autor: Elizabeth J de Koster, Olga Husson, Eveline W C M van Dam, G Sophie Mijnhout, Romana T Netea-Maier, Wim J G Oyen, Marieke Snel, Lioe-Fee de Geus-Oei, Dennis Vriens

Publikováno v: Endocrine Connections, Vol 11, Iss 8, Pp 1-12 (2022)

Objective: This study assessed the health-related quality of life (HRQoL) in patients undergoing 2-[18F]fluoro-2-deoxy-D-glucose (FDG)-PET/CT for an indeterminate (Bethesda III/IV) thyroid nodule. FDG-PET/CT accurately rules out malignancy and preven

Externí odkaz: https://doaj.org/article/05489f8b08c4475da624c16b7729c0c0

Adding the temporal domain to PET radiomic features.

Autor: Wyanne A Noortman, Dennis Vriens, Cornelis H Slump, Johan Bussink, Tineke W H Meijer, Lioe-Fee de Geus-Oei, Floris H P van Velden

Publikováno v: PLoS ONE, Vol 15, Iss 9, p e0239438 (2020)

BackgroundRadiomic features, extracted from positron emission tomography, aim to characterize tumour biology based on tracer intensity, tumour geometry and/or tracer uptake heterogeneity. Currently, radiomic features are derived from static images. H

Externí odkaz: https://doaj.org/article/6947448d28e844c3b294acba07ce5346

Development and External Validation of a PET Radiomic Model for Prognostication of Head and Neck Cancer

Autor: Wyanne A. Noortman, Nicolas Aide, Dennis Vriens, Lisa S. Arkes, Cornelis H. Slump, Ronald Boellaard, Jelle J. Goeman, Christophe M. Deroose, Jean-Pascal Machiels, Lisa F. Licitra, Renaud Lhommel, Alessandra Alessi, Erwin Woff, Karolien Goffin, Christophe Le Tourneau, Jocelyn Gal, Stéphane Temam, Jean-Pierre Delord, Floris H. P. van Velden, Lioe-Fee de Geus-Oei

Publikováno v: Cancers, 15(10):2681. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 15
Cancers; Volume 15; Issue 10; Pages: 2681
Cancers, 15(10):2681. MDPI
Noortman, W A, Aide, N, Vriens, D, Arkes, L S, Slump, C H, Boellaard, R, Goeman, J J, Deroose, C M, Machiels, J-P, Licitra, L F, Lhommel, R, Alessi, A, Woff, E, Goffin, K, le Tourneau, C, Gal, J, Temam, S, Delord, J-P, van Velden, F H P & de Geus-Oei, L-F 2023, ' Development and External Validation of a PET Radiomic Model for Prognostication of Head and Neck Cancer ', Cancers, vol. 15, no. 10, 2681 . https://doi.org/10.3390/cancers15102681
Cancers, 15, 10

AIM: To build and externally validate an [18F]FDG PET radiomic model to predict overall survival in patients with head and neck squamous cell carcinoma (HNSCC). METHODS: Two multicentre datasets of patients with operable HNSCC treated with preoperati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb11ebf7bc15d249d4d3f0994a3b4eba
https://research.vumc.nl/en/publications/df9b3a76-6039-4ed3-86d8-69b4d811533e

[(18)F]FDG-PET/CT radiomics for the identification of genetic clusters in pheochromocytomas and paragangliomas

Autor: Wyanne A. Noortman, Dennis Vriens, Lioe-Fee de Geus-Oei, Cornelis H. Slump, Erik H. Aarntzen, Anouk van Berkel, Henri J. L. M. Timmers, Floris H. P. van Velden

Publikováno v: European Radiology, 32, 10, pp. 7227-7236
European radiology, 32(10), 7227-7236. Springer
European Radiology, 32, 7227-7236
European Radiology, 32(10), 7227-7236. SPRINGER

Objectives Based on germline and somatic mutation profiles, pheochromocytomas and paragangliomas (PPGLs) can be classified into different clusters. We investigated the use of [18F]FDG-PET/CT radiomics, SUVmax and biochemical profile for the identific

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eee1d671d30ff6b4f9077f8c42df77d6
https://doi.org/10.1007/s00330-022-09034-5

Managing radioiodine refractory thyroid cancer: the role of dosimetry and redifferentiation on subsequent I-131 therapy

Autor: Rodney J. Hicks, Ellen Kapiteijn, Dennis Vriens, Lioe-Fee de Geus-Oei, James Nagarajah, Floris H. P. van Velden, Maaike Dotinga, Linda Heijmen

Publikováno v: Quarterly Journal of Nuclear Medicine and Molecular Imaging, 64, 250-264
Quarterly Journal of Nuclear Medicine and Molecular Imaging, 64(3), 250-264. EDIZIONI MINERVA MEDICA
Quarterly Journal of Nuclear Medicine and Molecular Imaging, 64, 3, pp. 250-264

Item does not contain fulltext Poor responses to iodine-131 (I-131) therapy can relate to either low iodine uptake and retention in thyroid cancer cells or to increased radioresistance. Both mechanisms are currently termed radioactive iodine (RAI)-re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8bc9e6441633575b6d5e256d73f9226
https://hdl.handle.net/2066/225889